These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4265209)

  • 1. Absence of effect of para-chlorophenylalanine on 5-hydroxyindoleacetic acid in cerebrospinal fluid in man.
    Sjöström R
    Psychopharmacologia; 1972; 27(4):393-6. PubMed ID: 4265209
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimation of brain amine metabolism in affective illness: cerebrospinal fluid studies utilizing probenecid.
    Post RM; Goodwin FK
    Psychother Psychosom; 1974; 23(1-6):142-58. PubMed ID: 4278087
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis.
    Sjöström R; Roos BE
    Eur J Clin Pharmacol; 1972 Jun; 4(3):170-6. PubMed ID: 4655292
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK; Post RM
    Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorometric measurement of 5-hydroxyindoleacetic acid (5HIAA) and tryptophan in human CSF: effects of high doses of probenecid.
    Bowers MB
    Biol Psychiatry; 1974 Aug; 9(1):93-8. PubMed ID: 4457119
    [No Abstract]   [Full Text] [Related]  

  • 6. 5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment.
    Sjöström R
    Eur J Clin Pharmacol; 1973 Aug; 6(2):75-80. PubMed ID: 4588853
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for a small functional pool of serotonin in neurohumoral transmission.
    Schaub RG; Meyers KM
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):29-36. PubMed ID: 235778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of manic-depressive psychosis from cerebrospinal fluid concentration of 5-hydroxyindoleacetic acid.
    Sjöström R
    Adv Biochem Psychopharmacol; 1974; 11(0):369-75. PubMed ID: 4845705
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.
    Korf J; van Praag HM; Sebens JB
    Biochem Pharmacol; 1971 Mar; 20(3):659-68. PubMed ID: 5150161
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
    Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
    [No Abstract]   [Full Text] [Related]  

  • 12. Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania.
    Dencker SJ; Malm U; Roos BE; Werdinius B
    J Neurochem; 1966 Dec; 13(12):1545-8. PubMed ID: 5962034
    [No Abstract]   [Full Text] [Related]  

  • 13. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
    Olsson R; Roos BE
    Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
    [No Abstract]   [Full Text] [Related]  

  • 14. A semiautomated fluorometric determination of 5-hydroxyindoles in the nanogram range.
    Korf J; Schutte HH; Venema K
    Anal Biochem; 1973 May; 53(1):146-53. PubMed ID: 4268064
    [No Abstract]   [Full Text] [Related]  

  • 15. Steady-state levels of probenecid and their relation to acid monoamine metabolites in human cerebrospinal fluid.
    Sjöström R
    Psychopharmacologia; 1972; 25(1):96-100. PubMed ID: 4261043
    [No Abstract]   [Full Text] [Related]  

  • 16. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
    Bowers MB; Heninger GR
    Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
    [No Abstract]   [Full Text] [Related]  

  • 17. Liquid chromatographic determination of homovanillic acid, 5-hydroxyindoleacetic acid and probenecid levels in human cerebrospinal fluid during probenecid test.
    Gagnieu MC; Menouni-Foray V; Guardiola P; Quincy C; Renaud B
    Clin Chim Acta; 1984 May; 139(1):1-12. PubMed ID: 6202442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 19. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes.
    Bowers MB
    J Nerv Ment Dis; 1974 May; 158(5):325-30. PubMed ID: 4823933
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
    Airaksinen EM; Kauko K
    Ann Clin Res; 1973 Dec; 5(6):392-4. PubMed ID: 4275983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.